HK1048588A1 - Phenylacetic acid compositions for treating or preventing hypercholesterolemia - Google Patents

Phenylacetic acid compositions for treating or preventing hypercholesterolemia

Info

Publication number
HK1048588A1
HK1048588A1 HK02108493A HK02108493A HK1048588A1 HK 1048588 A1 HK1048588 A1 HK 1048588A1 HK 02108493 A HK02108493 A HK 02108493A HK 02108493 A HK02108493 A HK 02108493A HK 1048588 A1 HK1048588 A1 HK 1048588A1
Authority
HK
Hong Kong
Prior art keywords
treating
phenylacetic acid
acid compositions
preventing hypercholesterolemia
hypercholesterolemia
Prior art date
Application number
HK02108493A
Other languages
English (en)
Inventor
Stanislaw R Burzynski
Original Assignee
Stanislaw R Burzynski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanislaw R Burzynski filed Critical Stanislaw R Burzynski
Publication of HK1048588A1 publication Critical patent/HK1048588A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK02108493A 2000-06-26 2002-11-22 Phenylacetic acid compositions for treating or preventing hypercholesterolemia HK1048588A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/603,320 US6987131B1 (en) 2000-06-26 2000-06-26 Phenylacetic acid compositions for treating or preventing hypercholesterolemia

Publications (1)

Publication Number Publication Date
HK1048588A1 true HK1048588A1 (en) 2003-04-11

Family

ID=24414934

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02108493A HK1048588A1 (en) 2000-06-26 2002-11-22 Phenylacetic acid compositions for treating or preventing hypercholesterolemia

Country Status (5)

Country Link
US (1) US6987131B1 (de)
EP (1) EP1206936B1 (de)
AT (1) ATE302603T1 (de)
DE (1) DE60112872T2 (de)
HK (1) HK1048588A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1291015A1 (de) 2001-09-10 2003-03-12 Lunamed AG Darreichungsformen mit verlängerter Wirkstofffreisetzung
ITMI20040876A1 (it) * 2004-04-30 2004-07-30 Univ Degli Studi Milano Inibitori delle istone deacetilasi-hdac-quali agenti ipolipidemizzati per la terapia e la prevenzione dell'arteriosclerosi e malattie cardiovascolari
CA2613204A1 (en) * 2005-06-29 2007-01-11 Rules-Based Medicine, Inc. Methods and kits for the diagnosis of acute coronary syndrome
KR100905419B1 (ko) 2008-09-11 2009-07-02 연세대학교 산학협력단 세스퀴테르펜 유도체의 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470970A (en) 1981-07-02 1984-09-11 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US5153226A (en) 1989-08-31 1992-10-06 Warner-Lambert Company Acat inhibitors for treating hypocholesterolemia
US5238947A (en) * 1990-04-12 1993-08-24 University Of Georgia Research Foundation, Inc. Synthetic piperidinediones with cytostatic activity
DE4200954A1 (de) 1991-04-26 1992-10-29 Bayer Ag Heterocyclisch substituierte phenylessigsaeurederivate
GB9111426D0 (en) 1991-05-28 1991-07-17 Ici Plc Chemical compounds
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
US5635532A (en) * 1991-10-21 1997-06-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
DE4208051A1 (de) 1992-03-13 1993-09-16 Bayer Ag Substituierte phenylessigsaeureamide
US5391575A (en) * 1994-05-04 1995-02-21 Burzynski; Stanislaw R. Method for treating neurofibromatosis
US6127419A (en) * 1998-11-23 2000-10-03 Burzynski; Stanislaw R. Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
CN1088597C (zh) * 1999-10-26 2002-08-07 合肥永生制药有限公司 尿多酸肽组合物及其用途

Also Published As

Publication number Publication date
ATE302603T1 (de) 2005-09-15
EP1206936A2 (de) 2002-05-22
DE60112872T2 (de) 2006-06-14
EP1206936A3 (de) 2002-09-04
US6987131B1 (en) 2006-01-17
DE60112872D1 (de) 2005-09-29
EP1206936B1 (de) 2005-08-24

Similar Documents

Publication Publication Date Title
DK0633259T3 (da) Hidtil ukendte sulfonylaminopyrimidiner, fremstilling heraf og deres anvendelse som lægemidler
GEP20043241B (en) Compounds for Treatment of Ischemia and Pharmaceutical Compositions Containing the Same
ES2133158T3 (es) Formulacion ci-981 oral, estable y proceso de preparacion del mismo.
BR0109703A (pt) Derivados de piperazina
RS20090086A (en) Nucleoside analogs with carobxamidine modified monocyclic base
EP0933993A4 (de) Substituierte cyclopentanderivate die als neuramidase-inhibitoren nuetzlich sind
ATE399171T1 (de) Camptothecinanaloge und deren zubereitungsmethoden
SE0104248D0 (sv) Method of treatment
DK1246625T3 (da) Anvendelser og sammensætninger af nitratestere til tilvejebringelse af sedering
DE69229442D1 (de) Substituierte dibenzooxazepin-verbindungen, pharmazeutische zusammensetzungen und verfahren zur verwendung
DE60022895D1 (de) Pdgf-rezeptor-kinase hemmende verbindungen, deren herstellung, reinigung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
WO2001081316A3 (en) Substituted phenyl farnesyltransferase inhibitors
DK0714387T3 (da) Hidtil ukendte bis-naphthalimider til behandling af cancer
HK1048588A1 (en) Phenylacetic acid compositions for treating or preventing hypercholesterolemia
GB9907571D0 (en) Compounds
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
GR3020190T3 (en) Diclofenac choline salt, a method for the preparation thereof and pharmaceutical compositions containing it
DE60005517D1 (de) Kaliumkanal-blockierende mittel
BR9606961A (pt) Composto processo para a sua preparação composição farmacêutica método par tratar um estado doentio capaz de ser amenizado pela administração de um inibidor de endotelina e aplicação do composto
AU2001244999A1 (en) Naphthamide neurokinin antagonists for use as medicaments
SE0004827D0 (sv) Therapeutic compounds
BR0317425A (pt) Sal de rabeprazol, composição farmacêutica contendo o mesmo e processo para sua preparação
EA200000532A3 (ru) НОВЫЕ СОЕДИНЕНИЯ 7-ОКСО-2,3,7,14-ТЕТРАГИДРО-1H-БЕНЗО[b]-ПИРАНО [3,2-h]АКРИДИНКАРБОКСИЛАТА, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
HK1045253A1 (en) Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
EP1413302A3 (de) Substitutierte Guanidinderivate zur Behandlung von Schmerz

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200628